Quantcast

Latest Channelopathy Stories

2014-07-16 23:04:17

ReportsnReports.com adds “OpportunityAnalyzer: Cystic Fibrosis - Opportunity Analysis and Forecasts to 2018 – Event-Driven Update” to its store. The majority of Cystic Fibrosis sales will come from the US, which will represent 60% of the market by 2018. Dallas, TX (PRWEB) July 16, 2014 Researcher estimates the 2012 sales for Cystic Fibrosis to be approximately $1.2 billion across the six markets covered in this forecast: the US, France, Germany, Italy, Spain and the UK. By the end...

2014-07-09 23:13:42

Los Angeles teen, Claire Wineland, receives prestigious award for her foundation’s dedication to making a difference in the lives of others living with cystic fibrosis. Los Angeles, CA (PRWEB) July 09, 2014 Claire’s Place Foundation, a nonprofit organization founded by 17-year-old Claire Wineland, was awarded “Small Nonprofit Organization of the Year” by the Los Angeles Business Journal for their work helping children and families affected by cystic fibrosis. On June 25th the Los...

2014-05-29 13:53:42

Johns Hopkins Medicine Understanding of mechanism could lead to new drug treatment A genetic variant linked to sudden cardiac death leads to protein overproduction in heart cells, Johns Hopkins scientists report. Unlike many known disease-linked variants, this one lies not in a gene but in so-called noncoding DNA, a growing focus of disease research. The discovery, reported in the June 5 issue of The American Journal of Human Genetics, also adds to scientific understanding of the...

2014-05-26 12:21:59

LONDON, May 26, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Cystic Fibrosis Therapeutics in Major Developed Markets to 2019 - CFTR Modulators Initiate Drive towards Personalized Treatment and Market Growthhttp://www.reportbuyer.com/pharma_healthcare/diseases/cystic_fibrosis_therapeutics_major_developed_markets_2019_cftr_modulators_initiate_drive_towards_personalized_treatment_market_growth.htmlCystic Fibrosis Therapeutics in Major Developed Markets...

2014-04-10 23:22:55

Novel Approach May Help to Prevent False Positive Cardiac Safety Findings in New Drug Development Philadelphia (PRWEB) April 10, 2014 ERT, a leading global solution provider for high-quality patient safety and efficacy endpoint data collection, today announced it has entered into an agreement with GE Healthcare that enables ERT to introduce the QT Guard Plus Analysis System to the clinical trial industry as part of its centralized cardiac safety solutions. The QT Guard Plus Analysis...

2014-03-13 17:11:30

A rare and potentially lethal disease of newborn babies whose bodies make too much insulin may be treatable with fish oils, according to researchers from The University of Manchester. The disease, called congenital hyperinsulinism, means that the infant's brain is starved of blood sugar which can lead to brain damage or long-term disability. But by giving the children purified fish oils similar to those used to treat some heart attack patients, alongside standard medical treatment, their...

2014-03-12 08:29:44

BOULDER, Colo., March 12, 2014 /PRNewswire/ -- N30 Pharmaceuticals, Inc. ("N30 Pharma") announced today that it has begun oral dosing of N91115 in a Phase 1 clinical trial. N91115, a novel inhibitor of S-nitrosoglutathione reductase (GSNOR), is being developed for the treatment of cystic fibrosis (CF). In preclinical studies, N91115 has been shown to rescue or "correct" F508del-CFTR, the most commonly occurring mutation in CF. It is the first oral GSNOR inhibitor to enter clinical...

2014-02-24 23:20:43

New research report “Cystic Fibrosis Therapeutics in Major Developed Markets to 2019 - CFTR Modulators Initiate Drive towards Personalized Treatment and Market Growth” worked out by GBI Research is now available at MarketPublishers.com. According to the study, the combined value of the cystic fibrosis (CF) markets in the top 8 developed economies is set to grow at a 30.4% CAGR through 2019. London, UK (PRWEB) February 24, 2014 In 2012, the combined value of the cystic fibrosis (CF)...

Cystic Fibrosis Flare-ups May Be Caused By Buttery Molecule Diacetyl
2014-02-24 06:52:58

By Michael Price, San Diego State University Katrine Whiteson and colleagues identified a lung-damaging molecule in higher concentrations in cystic fibrosis patients during symptom flare-ups. A molecule previously linked to lung injuries in factory workers producing microwave popcorn might play an important role in microbial infections of the lung suffered by people with cystic fibrosis (CF), according to a recent study led by San Diego State University postdoctoral researcher Katrine...

2014-02-06 23:25:01

ResearchMoz.us include new market research report "Cystic Fibrosis Therapeutics in Major Developed Markets to 2019" to its huge collection of research reports. Full Report @ http://www.researchmoz.us/cystic-fibrosis-therapeutics-in-major-developed-markets-to-2019-cftr-modulators-initiate-drive-towards-personalized-treatment-and-market-growth-report.html Albany, NewYork (PRWEB) February 06, 2014 GBI Research has released its pharma report “Cystic Fibrosis Therapeutics in Major...


Latest Channelopathy Reference Libraries

Cystic Fibrosis
2013-07-19 15:03:45

Cystic fibrosis, also called mucoviscidosis, is an autosomal recessive genetic disorder of the viscous secretions in the body. In turn, it effects the lungs, pancreas, liver, and intestines, as well as all other exocrine glands in the body. The most common genetic mutation that causes CF is a deletion of three nucleotides that results in a loss of phenylalanine, an amino acid at the 508th position on the protein. It should be noted, however, that there are over a thousand other mutations that...

More Articles (1 articles) »
Word of the Day
penuche
  • A fudgelike confection of brown sugar, cream or milk, and chopped nuts.
'Penuche' is a variant of 'panocha,' a coarse grade of sugar made in Mexico. 'Panocha' probably comes from the Spanish 'panoja, panocha,' ear of grain.
Related